Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Treatment of Regional Lymph Nodes in Breast Cancer-Not Recommended for All Patients With 1 to 3 Positive Auxiliary Nodes.

Identifieur interne : 000973 ( Main/Exploration ); précédent : 000972; suivant : 000974

Treatment of Regional Lymph Nodes in Breast Cancer-Not Recommended for All Patients With 1 to 3 Positive Auxiliary Nodes.

Auteurs : Jay R. Harris [États-Unis]

Source :

RBID : pubmed:27253737

Descripteurs français

English descriptors


DOI: 10.1001/jamaoncol.2016.0222
PubMed: 27253737


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Treatment of Regional Lymph Nodes in Breast Cancer-Not Recommended for All Patients With 1 to 3 Positive Auxiliary Nodes.</title>
<author>
<name sortKey="Harris, Jay R" sort="Harris, Jay R" uniqKey="Harris J" first="Jay R" last="Harris">Jay R. Harris</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27253737</idno>
<idno type="pmid">27253737</idno>
<idno type="doi">10.1001/jamaoncol.2016.0222</idno>
<idno type="wicri:Area/PubMed/Corpus">000796</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000796</idno>
<idno type="wicri:Area/PubMed/Curation">000796</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000796</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000796</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000796</idno>
<idno type="wicri:Area/Ncbi/Merge">008371</idno>
<idno type="wicri:Area/Ncbi/Curation">008371</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">008371</idno>
<idno type="wicri:Area/Main/Merge">000974</idno>
<idno type="wicri:Area/Main/Curation">000973</idno>
<idno type="wicri:Area/Main/Exploration">000973</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Treatment of Regional Lymph Nodes in Breast Cancer-Not Recommended for All Patients With 1 to 3 Positive Auxiliary Nodes.</title>
<author>
<name sortKey="Harris, Jay R" sort="Harris, Jay R" uniqKey="Harris J" first="Jay R" last="Harris">Jay R. Harris</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">JAMA oncology</title>
<idno type="eISSN">2374-2445</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Breast Neoplasms (pathology)</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Disease-Free Survival</term>
<term>Female</term>
<term>Humans</term>
<term>Lymph Nodes (pathology)</term>
<term>Lymphatic Metastasis (radiotherapy)</term>
<term>Lymphedema (etiology)</term>
<term>Radiotherapy, Adjuvant (adverse effects)</term>
<term>Radiotherapy, Adjuvant (methods)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème (étiologie)</term>
<term>Métastase lymphatique (radiothérapie)</term>
<term>Noeuds lymphatiques (anatomopathologie)</term>
<term>Radiothérapie adjuvante ()</term>
<term>Radiothérapie adjuvante (effets indésirables)</term>
<term>Survie sans rechute</term>
<term>Tumeurs du sein (anatomopathologie)</term>
<term>Tumeurs du sein (radiothérapie)</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Radiotherapy, Adjuvant</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Noeuds lymphatiques</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Radiothérapie adjuvante</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Radiotherapy, Adjuvant</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Breast Neoplasms</term>
<term>Lymph Nodes</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en">
<term>Breast Neoplasms</term>
<term>Lymphatic Metastasis</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr">
<term>Métastase lymphatique</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr">
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Disease-Free Survival</term>
<term>Female</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Femelle</term>
<term>Humains</term>
<term>Radiothérapie adjuvante</term>
<term>Survie sans rechute</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Massachusetts</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Massachusetts">
<name sortKey="Harris, Jay R" sort="Harris, Jay R" uniqKey="Harris J" first="Jay R" last="Harris">Jay R. Harris</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000973 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000973 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:27253737
   |texte=   Treatment of Regional Lymph Nodes in Breast Cancer-Not Recommended for All Patients With 1 to 3 Positive Auxiliary Nodes.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:27253737" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024